Table 1.
Coactivators | Peptides | Peptide sequences | Motifs | Relative binding valuesa | |||
---|---|---|---|---|---|---|---|
E2 | BPA | BPAF | BPS | ||||
SRC1 | NCOA1_737_759 | ASKKKESKDHQLLRYLLDKDEKD | LxxLL749 | 47.5 | 2.5 | — | 1.4 |
NCOA1_620_643 | SDGDSKYSQTSHKLVQLLTTTAEQ | LxxLL633 | 45.1 | 2.0 | — | 3.6 | |
NCOA1_1421_1441 | TSGPQTPQAQQKSLLQQLLTE | LxxLL1435 | 5.6 | — | — | 1.3 | |
NCOA1_677_700 | PSSHSSLTERHKILHRLLQEGSPS | LxxLL690 | 5.5 | — | — | 1.6 | |
SRC2 | NCOA2_628_651 | GQSRLHDSKGQTKLLQLLTTKSDQ | LxxLL641 | 12.8 | 1.3 | — | 1.9 |
NCOA2_677_700 | STHGTSLKEKHKILHRLLQDSSSP | LxxLL690 | 9.7 | — | — | 1.7 | |
NCOA2_733_755 | EPVSPKKKENALLRYLLDKDDTK | LxxLL745 | 8.6 | — | — | 1.4 | |
SRC3 | NCOA3_609_631 | KKKGQGVIDKDSLGPLLLQALDG | LxxLL113 | 21.1 | — | — | 2.4 |
NCOA3_609_631_C627S | QRGPLESKGHKKLLQLLTCSSDD | LxxLL621 | 13.1 | — | — | 1.7 | |
NCOA3_725_747 | MHGSLLQEKHRILHKLLQNGNSP | LxxLL685 | 6.3 | — | — | 1.2 | |
NCOA3_673_695 | QRGPLESKGHKKLLQLLTSSSDD | LxxLL621 | 5.8 | — | — | — | |
NCOA3_104_123_N-KKK | HGSQNRPLLRNSLDDLLGPPSNA | LxxLL1041 | 2.5 | — | 1.5 | — | |
PRGC1_130_155 | DGTPPPQEAEEPSLLKKLLLAPANTQ | LxxLL144 | 5.2 | 1.1 | — | 1.9 | |
PRGC1_134_154 | PPQEAEEPSLLKKLLLAPANT | LxxLL144 | 5.8 | 0.9 | — | 1.5 | |
PRGC2_146_166 | PAPEVDELSLLQKLLLATSYP | LxxLL156 | 7.1 | — | — | 1.5 | |
PRGC2_338_358 | AEFSILRELLAQDVLCDVSKP | LxxLL343 | 6.0 | — | — | — |
Note: —, no binding; BPA, bisphenol A; BPAF, bisphenol AF; BPS, bisphenol S; E2, estradiol.
Relative binding value shows each peptide binding relative to the control, 2% DMSO. (Cutoff: binding value, ; relative binding, ; p-value, .)